Upload
temiong
View
218
Download
0
Embed Size (px)
Citation preview
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 1/9
Effects of Effects of AdrenergicAdrenergic Drugs Depend on:Drugs Depend on:
1) Expression of the receptor (type and number) in1) Expression of the receptor (type and number) in
a specific tissue/organ (i.e., bronchial smootha specific tissue/organ (i.e., bronchial smooth
muscle hasmuscle has β22 receptors only)receptors only)
2) The affinity of the drug for a2) The affinity of the drug for a specif adrenergicspecif adrenergic
receptor (i.e., NE=receptor (i.e., NE=α >>β11))
3) Indirect or reflex effects (i.e., NE decrease HR)3) Indirect or reflex effects (i.e., NE decrease HR)
4) Know: receptor expression and affinity4) Know: receptor expression and affinity
for the drug = predict effect in most cases.for the drug = predict effect in most cases.
α11R R
β11R R β22R R
α22R R
β22R R Synthesis
BlockersBlockersAmphetamine
CocaineCocaine
MetyrosineMetyrosine
ReserpineReserpine
GuanethidineGuanethidineBretyliumBretylium
Uptake 1
Uptake 2
MAO
ImipramineImipramine
Storage
Secretion
DA Transport
Clonidine
NE,Epi
NE
Epi
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 2/9
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 3/9
Epinephrine DopamineNorepinephrine
α1/2R β1/2R DAR
NENE-->>α1/2>1/2>β1>1> β22
EpiEpi-->> β1/2>1/2>α1/21/2
DADA-->D1/2>>D1/2>β1>>1>>α
α1R Smooth muscle contractionSmooth muscle contraction
Blood vessels:vasoconst.
Iris radial musc:->mydriasis
Skin: pilomotor musc.
α2R
PresynapticPresynaptic TerminalsTerminalsdecrease NE releasedecrease NE release
Postsynaptic TerminalsPostsynaptic Terminals
CNS, multipleCNS, multiple
Platelet aggregationPlatelet aggregation
β1R HEARTHEART
Increase: contraction,
HR, output, conduction
β2R SmoothSmooth muscmusc. relaxation. relaxation
LUNG & UTERUSLUNG & UTERUS
β3R LipolysisLipolysis andand
ThermogenesisThermogenesis
SmoothSmooth
muscmusc.relaxation.relaxation
RENAL &RENAL &
SPLANCHNICSPLANCHNIC
β1R HEARTHEART
Increase: contraction,
HR, output, conduction
100100
5050β1
StartStart StartStart StartStart StartStartStopStop StopStop StopStop StopStop
Heart RateHeart Rate
180180
6060
BloodBloodPressurePressure
120120
SPSP
MAPMAP
DPDP
SPSP
MAPMAP
DPDP
SPSP
MAPMAP
DPDP
MAPMAP
SPSP
DPDP
β1 β1 b e a t s /
b e a t s /
m i n
m i n
m
m H
g
m
m H
g
PeripheralPeripheralResistanceResistance
α1
β2 β2D1
ReflexReflex
BradycBradyc..
NENE(10mg/min)(10mg/min)
EPIEPI(10mg/min)(10mg/min)
IsoprotIsoprot..(10mg/min)(10mg/min)
DopamineDopamine(10mg/min)(10mg/min)
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 4/9
α1
100100
5050
StartStart StopStop
Heart RateHeart Rate
180180
6060
BloodBloodPressurePressure
120120
SPSP
MAPMAP
DPDP
b e a t s /
b e a t s /
m i n
m i n
m m H
g
m m H
g
PeripheralPeripheralResistanceResistance
ReflexReflex
BradycBradyc..
NENE(10mg/min)(10mg/min)
α11 receptors in vascularreceptors in vascularsmooth muscle= vasoconstrictionsmooth muscle= vasoconstriction
VasomotorCenterCenter
NucleusNucleus
TractusTractusSolitariusSolitariusInhibitoryInhibitory
NeuronNeuron
AutonomicAutonomicGangliaGanglia
NENE
NENE
AChACh
MotorMotorNucleusNucleusVagusVagus
BaroreceptorsBaroreceptors( res( responponse tose to
chanchangesges in MAPin MAP
AChACh
AChACh↓HR HR NENE
AChACh
NENE
Excitatory NeuronExcitatory Neuron
100100
5050β1
StartStart StopStopHeart RateHeart Rate
180180
6060
BloodBloodPressurePressure
120120
SPSP
MAPMAP
DPDP
b e a t s /
b e a t s /
m i n
m i n
m
m H
g
m
m H
g
PeripheralPeripheralResistanceResistance
β2
EPIEPI(10mg/min)(10mg/min)
HR HR
COCO
β2
Low DosesLow Doses
High DosesHigh Doses α1
SA node & Atria:SA node & Atria:RateRate
ContractilityContractility
AutomaticityAutomaticity
VelocVeloc. Conduct.. Conduct.
AV node &AV node &Conduction:Conduction:Velocity conductionVelocity conduction
Effect. Refract. PeriodEffect. Refract. Period
VentriculeVentricule::Contractility Work Contractility Work
O2 consumption EfficiencyO2 consumption Efficiency
β2
α1α1
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 5/9
100100
5050
Heart RateHeart Rate
180180
6060
BloodBloodPressurePressure
120120
b e a t s /
b e a t s /
m i n
m i n
m m H
g
m m H
g
PeripheralPeripheralResistanceResistanceβ2
β1
StartStart StopStop
SPSP
MAPMAP
DPDP
β1
β2
IsoproterenolIsoproterenolStartStart StopStop
SPSP
MAPMAP
DPDP
β1
D1D1Renal/Renal/
SplachnicSplachnic
DopamineDopamine
HR HR HR HR
COCOHigher DosesHigher Doses
SkeletalSkeletal muscmusc..
COCO
HEART: Most effects areHEART: Most effects are β11
ElecticalElectical:Increase in Rate,:Increase in Rate, AutomaticityAutomaticity,, VelocVeloc. Conduct..;. Conduct..;
Decrease in Effect. Refract. PeriodDecrease in Effect. Refract. Period
Mechanical: Increase contractility, CO, work and O2 consumptionMechanical: Increase contractility, CO, work and O2 consumption
BLOOD VESSELS: Depends on the agonist and vascular bedBLOOD VESSELS: Depends on the agonist and vascular bed
Skin/MucousSkin/Mucous membmemb α −> VasoconstVasoconst..
SplanchnicSplanchnic α −> VasoconstVasoconst. D1. D1 −> vasodilatvasodilat..
SkeletalSkeletal muscmusc.. α −> VasoconstVasoconst.. β22 −> vasodilatvasodilat..
VenoseVenose ToneTone α −> VasoconstVasoconst.. β22 −> vasodilatvasodilat..
Respiratory Tract:Respiratory Tract: β2 in bronchia and2 in bronchia and α1 in vessels1 in vessels
Bronchial SmoothBronchial Smooth muscmusc.. β22 −> dilationdilation
VesselsVessels α −> VasoconstVasoconst..
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 6/9
EYE:EYE:
RadialRadial pupillarypupillary dilatordilator α −> contractioncontraction
IntraocularIntraocular PressurePressure α −> decreasesdecreases β −> increasesincreases
GASTROINTESTINAL:GASTROINTESTINAL:
Smooth muscleSmooth muscle α andand β −> relaxationrelaxation
GENITOURINARY:GENITOURINARY:
UterusUterus β22 −> relaxationrelaxationBladder base, urethral sphincter,Bladder base, urethral sphincter,
prostateprostate α −> contraction (urine continence)contraction (urine continence)DuctusDuctus deferens, seminaldeferens, seminal vesves.,.,
prostateprostate α −> contraction (ejaculation)contraction (ejaculation)
METABOLIC:METABOLIC:Fat cellsFat cells β33 −> increasesincreases lipolysislipolysisLiverLiver β −> glycogenolysisglycogenolysis
CellsCells β22 −> increases K uptakeincreases K uptakeInsulin/Insulin/ReninRenin//GlucagonGlucagonsecretionsecretion β22 −> increaseincrease α22 −> decreasedecrease
Mechanism of ActionMechanism of Action
1) Directly Acting1) Directly Acting SympathomimeticsSympathomimetics
Their effects are not abolished by chronicTheir effects are not abolished by chronic denervationdenervation
of postof post--ganglionicganglionic neurons,neurons, reserpinereserpine or cocaineor cocaine
2) Indirectly Acting2) Indirectly Acting SympathomimeticsSympathomimetics
Their effect is abolished byTheir effect is abolished by reserpinereserpine,, denervationdenervation of of
postpost--ganglionicganglionic neurons, and cocaineneurons, and cocaine
3) Mixed action3) Mixed action
Some effectsSome effects arepresentarepresent afterafter reserpinereserpine or cocaine.or cocaine.
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 7/9
HO
CH
OH
CH2 NCH3
H
PhenylephrinePhenylephrine ((NeosynephrineNeosynephrine))(αα1 only, direct acting)1 only, direct acting)
H3CO
CH
OH
CH NH2
CH3H3CO
MethoxamineMethoxamine(αα1 only, direct acting)1 only, direct acting)
HO
CH
OH
CH NH2
CH3
HO
α--MethylnorepinephrineMethylnorepinephrine
(αα1>>1>>β1, long1, long--acting)acting)
Systemic VasoconstrictorsSystemic Vasoconstrictors((hypotensionhypotension))
Ophtalmic MydriaticsOphtalmic MydriaticsNasal DecongestantsNasal DecongestantsAppetite SuppressantAppetite Suppressant
HO
HO
CH
OH
CH2 NH2
For ComparisonFor ComparisonNorepinephrineNorepinephrine
(αα1>1>β1)1)
MetaraminolMetaraminol(αα1>>1>>β1, direct and indirect acting1, direct and indirect acting
longlong--action)action)
HO
CH
OH
CH NH2
CH3
α11--SelectiveSelective
TetrahydrozolineTetrahydrozoline
(Visine;(Visine;α1 only)1 only)
C
NH CH2
CH2N
α22--SelectiveSelective
Cl
CH2 C NH
OGuanfacineGuanfacine
(αα2 in CNS, decreases BP)2 in CNS, decreases BP)
Cl
C
NH
NH2
Cl
CH N NH C
NH
NH2
Cl GuanabenzGuanabenz
(αα2 in CNS, decreases BP)2 in CNS, decreases BP)
Cl
NH N
ClN
H
N
ClonidineClonidine ((CatapresCatapres))(αα2 agonist,2 agonist, α1 antagonist).1 antagonist).
AntihypertensiveAntihypertensive..PosturalPostural hypotensionhypotension
ActivatesActivates α2 in CNS2 in CNS-->decreases:>decreases:NE release, BP & HR. Sedation andNE release, BP & HR. Sedation and
sexual dysfunction.sexual dysfunction.
HO
CH2 CH NH2
CH3
HO
α--MethylDOPAMethylDOPA
AntihypertensiveAntihypertensive, CNS act. It is, CNS act. It is
metabolized tometabolized to α--methylNEmethylNE andand
displaces NE from storage.displaces NE from storage.
ActivatesActivates presynappresynap.. α22
COOH
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 8/9
CH3
CH
OH
CH2 NCH3
H
EphedrineEphedrine (β>αβ>α))
Crosses BBBCrosses BBB-->CNS stimulant>CNS stimulantBroncodilatorBroncodilator
α && β SelectivitySelectivityHO
CH
OH
CH2 NCH3
H
For Comparison:For Comparison:EpinephrineEpinephrine
(β>αβ>α))
HO
NH2
CH3
CH2 CH2
AmphetamineAmphetamine
CH3
CH2 CH2 NH2
HydroxyamphetamineHydroxyamphetamine
HO
Potency: l > Potency: l >periphery,periphery, d >d >CNSCNS
Increase SP & DP, reflex decrease HR,Increase SP & DP, reflex decrease HR, arrithmiasarrithmias
ReleasesReleases biogenicbiogenic amines from storage sites.amines from storage sites.
AnoreticAnoretic-->used in obesity. Attention deficit>used in obesity. Attention deficit
hyperactivity disorder.hyperactivity disorder.
Toxicity: restlessness, hyperactive reflexes,Toxicity: restlessness, hyperactive reflexes,
insomnia, convulsions and coma.insomnia, convulsions and coma.
Treatment: NaTreatment: Na--NitoprusideNitopruside oror α--blockerblocker--
phentolaminephentolamine ((hyperthypert.) sedation, urine acidification,.) sedation, urine acidification,
β--SelectiveSelectiveHO
CH
OH
CH2 NCH3
H
EpinephrineEpinephrine(β>αβ>α))
Used in anaphylactic shock, cardiac arrestUsed in anaphylactic shock, cardiac arrest
HO
HO
CH
OH
CH2 NCH(CH3)2
H
IsoproterenolIsoproterenol
(ββ only)only)
Used inUsed in bradycardiabradycardia or heart shock or heart shock
HO
HO
CH2 CH2 NHCH H2C
DobutamineDobutamine (ββ only)only)
((--) isomer) isomer α1 agonist, (+)1 agonist, (+) α 1 antagonist1 antagonist
β--receptor agonist: (+)>>(receptor agonist: (+)>>(--))
InotropicInotropic>>>>chronotropicchronotropic, TPR unchanged, TPR unchanged
Indications: Cardiac Heart Failure, MI.Indications: Cardiac Heart Failure, MI.
HOCH3
H2C OH
8/8/2019 Ad Re Nag On
http://slidepdf.com/reader/full/ad-re-nag-on 9/9
β22--SelectiveSelectiveHO
CH
OH
CH2 N
CH(CH3)2
H
MetaproterenolMetaproterenol ((AlupentAlupent))
(β2>>ββ2>>β1)1)
HO
HO
CH CH NH CH2
RitodrineRitodrine (β2>>ββ2>>β1)1)
HO H2C OH
CH3
HO
CH
OH
CH2 NCH(CH3)3
H
HOTerbutalineTerbutaline ((BrethineBrethine))
(β2>>ββ2>>β1)1)
BroncodilatorsBroncodilatorsUterine relaxantUterine relaxantNo COMTNo COMT substsubst..
HO
CH
OH
CH2 N
CH(CH3)2
H
AlbuterolAlbuterol ((VentolinVentolin))
(β2>>ββ2>>β1)1)
CH2-HO
HO
CH
OH
CH2 NCH(CH3)2
H
IsoproterenolIsoproterenol
(β1+2β1+2 only)only)
HO
use to compareuse to compare